Neuraxial Preservative Free Morphine for Normal Spontaneous Vaginal Delivery

• Status: Recruiting
• Trial end date: 2022-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

Patients presenting for normal spontaneous vaginal delivery who have a neuraxial anesthestic will be randomized to receive preservative free morphine or saline placebo after delivery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Icahn School of Medicine at Mount Sinai
• Treatments: Morphine

Criteria

Inclusion Criteria:

• Pregnant women in labor

Exclusion Criteria:

• Not a candidate for neuraxial anesthesia

• Patient refusal

• Allergy to morphine

• Patients with chronic pain syndromes